JILL MILLER: Open Payments
NPI 1952650749 · EVANSVILLE, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,146 in 65 payments from 17 companies in 2025. Trend: 2023 $522 · 2024 $1,060 · 2025 $1,146
Food & beverage: $1,146
| Company | Payments | Amount |
|---|---|---|
| Insulet Corporation | 18 | $288 |
| Novo Nordisk Inc | 13 | $167 |
| Tandem Diabetes Care, Inc. | 11 | $164 |
| BETA BIONICS, INC. | 4 | $97 |
| Medtronic, Inc. | 2 | $90 |
| Novartis Pharmaceuticals Corporation | 3 | $49 |
| Xeris Pharmaceuticals, Inc. | 2 | $44 |
| SANOFI-AVENTIS U.S. LLC | 2 | $39 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $36 |
| CeQur Corporation | 1 | $32 |
Products named: Omnipod, t:slim X2 Insulin Pump with Control-IQ, iLet Bionic Pancreas, Rybelsus, MINIMED 780G, Ozempic, RECORLEV, TZIELD.
Industry payments across IN — which companies pay providers there.
